{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:44:47Z","timestamp":1791179087096,"version":"4.1.0"},"reference-count":61,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Historically, all efforts against tuberculosis were focused on rapid diagnosis and effective treatment to break the chain of transmission of Mycobacterium tuberculosis. However, in the last few years, more and more evidence has been found on the dramatic consequences of the condition defined as post-tuberculosis lung disease (PTLD). Approximately one third of patients surviving pulmonary tuberculosis face considerable ongoing morbidities, including respiratory impairment, psychosocial challenges, and reduced health-related quality of life after treatment completion. Given the important global and local burden of tuberculosis, as well as the estimated burden of PTLD, the development of a consensus document by a Brazilian scientific society-Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)-was considered urgent for the prevention and management of this condition in order to allocate resources to and within tuberculosis services appropriately and serve as a guide for health care professionals. A team of eleven pulmonologists and one methodologist was created by the SBPT to review the current evidence on PTLD and develop recommendations adapted to the Brazilian context. The expert panel selected the topics on the basis of current evidence and international guidelines. During the first phase, three panel members drafted the recommendations, which were divided into three sections: definition and prevalence of PTLD, assessment of PTLD, and management of PTLD. In the second phase, all panel members reviewed, discussed, and revised the recommendations until a consensus was reached. The document was formally approved by the SBPT in a special session organized during the 2023 SBPT Annual Conference.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20230269","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:51:27Z","timestamp":1701186687000},"page":"e20230269","source":"Crossref","is-referenced-by-count":12,"title":["Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease"],"prefix":"10.36416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-2734","authenticated-orcid":false,"given":"Denise","family":"Rossato Silva1","sequence":"first","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5226-4372","authenticated-orcid":false,"given":"Ana","family":"Paula Santos2,3","sequence":"additional","affiliation":[{"name":"2. Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro \u2013 UFRJ \u2013 Rio de Janeiro (RJ) Brasil. 3. Hospital Universit\u00e1rio Pedro Ernesto, Universidade do Estado do Rio de Janeiro \u2013 UERJ \u2013 Rio de Janeiro (RJ) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-1623","authenticated-orcid":false,"given":"Dina","family":"Visca4,5","sequence":"additional","affiliation":[{"name":"4. Dipartimento di Pneumologia Riabilitativa, Istituti Clinici Scientifici Maugeri \u2013 IRCCS \u2013 Tradate, Italia. 5. Dipartimento di Medicina e Chirurgia, Malattie Respiratorie, Universit\u00e0 Degli Studi Dell\u2019Insubria, Varese-Como, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-8679","authenticated-orcid":false,"given":"Sidney","family":"Bombarda6","sequence":"additional","affiliation":[{"name":"6. Secretaria de Estado da Sa\u00fade de S\u00e3o Paulo, Centro de Vigil\u00e2ncia Epidemiol\u00f3gica Professor Alexandre Vranjac \u2013 CVE-SSP-SP \u2013 S\u00e3o Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-1082","authenticated-orcid":false,"given":"Margareth","family":"Maria Pretti Dalcolmo7","sequence":"additional","affiliation":[{"name":"7. Centro de Refer\u00eancia H\u00e9lio Fraga, Funda\u00e7\u00e3o Oswaldo Cruz \u2013 Fiocruz \u2013 Rio de Janeiro (RJ) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-7715","authenticated-orcid":false,"given":"Tatiana","family":"Galv\u00e3o8","sequence":"additional","affiliation":[{"name":"8. Hospital Universit\u00e1rio Professor Edgar Santos. Universidade Federal da Bahia \u2013 UFBA \u2013 Salvador (BA) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-4472","authenticated-orcid":false,"given":"Silvana","family":"Sp\u00edndola de Miranda9","sequence":"additional","affiliation":[{"name":"9. Faculdade de Medicina, Universidade Federal de Minas Gerais \u2013 UFMG \u2013 Belo Horizonte (MG) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-7311","authenticated-orcid":false,"given":"Ana","family":"Alice Amaral Ibiapina Parente10","sequence":"additional","affiliation":[{"name":"10. Departamento de Pediatria, Universidade Federal do Rio de Janeiro \u2013 UFRJ \u2013 Rio de Janeiro (RJ) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-5906","authenticated-orcid":false,"given":"Marcelo","family":"Fouad Rabahi11","sequence":"additional","affiliation":[{"name":"11. Faculdade de Medicina, Universidade Federal de Goi\u00e1s, Goi\u00e2nia (GO) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3074-445X","authenticated-orcid":false,"given":"Roberta","family":"Karla Barbosa de Sales12","sequence":"additional","affiliation":[{"name":"12. Divis\u00e3o de Pneumologia, Instituto do Cora\u00e7\u00e3o \u2013 InCor \u2013 Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-574X","authenticated-orcid":false,"given":"Giovanni","family":"Battista Migliori13","sequence":"additional","affiliation":[{"name":"13. Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri \u2013 IRCCS \u2013 Tradate, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-6738","authenticated-orcid":false,"given":"Fernanda","family":"Carvalho de Queiroz Mello2","sequence":"additional","affiliation":[{"name":"2. Instituto de Doen\u00e7as do T\u00f3rax, Universidade Federal do Rio de Janeiro \u2013 UFRJ \u2013 Rio de Janeiro (RJ) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.   Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis. 2020;24(8):820-828. https:\/\/doi.org\/10.5588\/ijtld.20.0067","DOI":"10.5588\/ijtld.20.0067"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.  van Kampen SC, Wanner A, Edwards M, Harries AD, Kirenga BJ, Chakaya J, et al. International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review. BMJ Glob Health. 2018;3(4):e000745. https:\/\/doi.org\/10.1136\/bmjgh-2018-000745","DOI":"10.1136\/bmjgh-2018-000745"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.    van Kampen SC, Wanner A, Edwards M, Harries AD, Kirenga BJ, Chakaya J, et al. International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review. BMJ Glob Health. 2018;3(4):e000745. https:\/\/doi.org\/10.1136\/bmjgh-2018-000745","DOI":"10.1136\/bmjgh-2018-000745"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.   Nightingale R, Carlin F, Meghji J, McMullen K, Evans D, van der Zalm MM, et al. Post-TB health and wellbeing. Int J Tuberc Lung Dis. 2023;27(4):248-283. https:\/\/doi.org\/10.5588\/ijtld.22.0514","DOI":"10.5588\/ijtld.22.0514"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.  Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129-1137. https:\/\/doi.org\/10.1016\/S1473-3099(19)30309-3","DOI":"10.1016\/s1473-3099(19)30309-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.     Ranzani OT, Rodrigues LC, Bombarda S, Minto CM, Waldman EA, Carvalho CRR. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in S\u00e3o Paulo state, Brazil, 2010-15: a population-based, longitudinal study. Lancet Infect Dis. 2020;20(1):123-132. https:\/\/doi.org\/10.1016\/S1473-3099(19)30518-3","DOI":"10.1016\/s1473-3099(19)30518-3"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.    Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration. 2021;100(8):751-763. https:\/\/doi.org\/10.1159\/000512531","DOI":"10.1159\/000512531"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.    Visca D, D Ambrosio L, Centis R, Pontali E, Tiberi S, Migliori GB. Post-TB disease: a new topic for investigation-and why it matters. Int J Tuberc Lung Dis. 2021;25(4):258-261. https:\/\/doi.org\/10.5588\/ijtld.21.0040","DOI":"10.5588\/ijtld.21.0040"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.   Dodd PJ, Yuen CM, Jayasooriya SM, van der Zalm MM, Seddon JA. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis. 2021;21(7):984-992. https:\/\/doi.org\/10.1016\/S1473-3099(20)30919-1","DOI":"10.1016\/s1473-3099(20)30919-1"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.  Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, et al. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010;10:259. https:\/\/doi.org\/10.1186\/1471-2458-10-259","DOI":"10.1186\/1471-2458-10-259"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.   Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. 2015;46(4):1104-1112. https:\/\/doi.org\/10.1183\/13993003.02325-2014","DOI":"10.1183\/13993003.02325-2014"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.  Allwood BW, Stolbrink M, Baines N, Louw E, Wademan DT, Lupton-Smith A, et al. Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function. Int J Tuberc Lung Dis. 2021;25(4):262-270. https:\/\/doi.org\/10.5588\/ijtld.20.0906","DOI":"10.5588\/ijtld.20.0906"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.   Menzies NA, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae [published correction appears in Lancet Glob Health. 2022 Mar;10(3):e336]. Lancet Glob Health. 2021;9(12):e1679-e1687. https:\/\/doi.org\/10.1016\/S2214-109X(21)00367-3","DOI":"10.1016\/s2214-109x(21)00367-3"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.   Pontali E, Silva DR, Marx FM, Caminero JA, Centis R, D\u2019Ambrosio L, et al. Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs. Arch Bronconeumol. 2022;58(11):754-763. https:\/\/doi.org\/10.1016\/j.arbres.2022.05.010","DOI":"10.1016\/j.arbres.2022.05.010"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.  Martinez-Garcia MA, Guan WJ, de-la-Rosa D, Athanazio R, Oscullo G, Shi MX, et al. Post-TB bronchiectasis: from pathogenesis to rehabilitation. Int J Tuberc Lung Dis. 2023;27(3):175-181. https:\/\/doi.org\/10.5588\/ijtld.22.0566","DOI":"10.5588\/ijtld.22.0566"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.   Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, et al Post tuberculosis treatment infectious complications. Int J Infect Dis. 2020;92S:S41-S45. https:\/\/doi.org\/10.1016\/j.ijid.2020.02.032","DOI":"10.1016\/j.ijid.2020.02.032"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.   Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al Pulmonary impairment after tuberculosis. Chest. 2007;131(6):1817-1824. https:\/\/doi.org\/10.1378\/chest.06-2949","DOI":"10.1378\/chest.06-2949"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.  Tiberi S, Torrico MM, Rahman A, Krutikov M, Visca D, Silva DR, et al. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. J Bras Pneumol. 2019;45(2):e20180324. https:\/\/doi.org\/10.1590\/1806-3713\/e20180324","DOI":"10.1590\/1806-3713\/e20180324"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.  Migliori GB, Caminero Luna J, Kurhasani X, van den Boom M, Visca D, D\u2019Ambrosio L, et al. History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis. Presse Med. 2022;51(3):104112. https:\/\/doi.org\/10.1016\/j.lpm.2022.104112","DOI":"10.1016\/j.lpm.2022.104112"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.   Mpagama SG, Msaji KS, Kaswaga O, Zurba LJ, Mbelele PM, Allwood BW, et al. The burden and determinants of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):846-853. https:\/\/doi.org\/10.5588\/ijtld.21.0278","DOI":"10.5588\/ijtld.21.0278"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.   Miller TL, Wilson FA, Pang JW, Beavers S, Hoger S, Sharnprapai S, et al. Mortality hazard and survival after tuberculosis treatment. Am J Public Health. 2015;105(5):930-937. https:\/\/doi.org\/10.2105\/AJPH.2014.302431","DOI":"10.2105\/ajph.2014.302431"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.    Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018;27(147):170077. https:\/\/doi.org\/10.1183\/16000617.0077-2017","DOI":"10.1183\/16000617.0077-2017"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.    Silva DR, Freitas AA, Guimar\u00e3es AR, D\u2019Ambrosio L, Centis R, Mu\u00f1oz-Torrico M, et al. Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts. J Bras Pneumol. 2022;48(2):e20210515.","DOI":"10.36416\/1806-3756\/e20210515"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.   Meghji J, Simpson H, Squire SB, Mortimer K. A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS One. 2016;11(8):e0161176. https:\/\/doi.org\/10.1371\/journal.pone.0161176","DOI":"10.1371\/journal.pone.0161176"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.   Maleche-Obimbo E, Odhiambo MA, Njeri L, Mburu M, Jaoko W, Were F, et al. Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis. PLOS Glob Public Health. 2022;2(12):e0000805. https:\/\/doi.org\/10.1371\/journal.pgph.0000805","DOI":"10.1371\/journal.pgph.0000805"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.    Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, et al. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797-813. https:\/\/doi.org\/10.5588\/ijtld.21.0425","DOI":"10.5588\/ijtld.21.0425"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.   Chesov D, Butov D, Reimann M, Heyckendorf J, Myasoedov V, Butov T, et al. Impact of lung function on treatment outcome in patients with TB. Int J Tuberc Lung Dis. 2021;25(4):277-284. https:\/\/doi.org\/10.5588\/ijtld.20.0949","DOI":"10.5588\/ijtld.20.0949"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.   Mu\u00f1oz-Torrico M, Rendon A, Centis R, D\u2019Ambrosio L, Fuentes Z, Torres-Duque C, et al. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?. J Bras Pneumol. 2016;42(5):374-385. https:\/\/doi.org\/10.1590\/S1806-37562016000000226","DOI":"10.1590\/s1806-37562016000000226"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.   Tiberi S, Torrico MM, Rahman A, Krutikov M, Visca D, Silva DR, et al. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. J Bras Pneumol. 2019;45(2):e20180324. https:\/\/doi.org\/10.1590\/1806-3713\/e20180324","DOI":"10.1590\/1806-3713\/e20180324"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.   Mu\u00f1oz-Torrico M, Cid-Ju\u00e1rez S, Gochicoa-Rangel L, Torre-Bouscolet L, Salazar-Lezama MA, Villarreal-Velarde H, et al. Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2020;24(7):700-705. https:\/\/doi.org\/10.5588\/ijtld.19.0809","DOI":"10.5588\/ijtld.19.0809"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.    Ross J, Ehrlich RI, Hnizdo E, White N, Churchyard GJ. Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax. 2010;65(11):1010-1015. https:\/\/doi.org\/10.1136\/thx.2009.129999","DOI":"10.1136\/thx.2009.129999"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.   Bongomin F. Post-tuberculosis chronic pulmonary aspergillosis: An emerging public health concern. PLoS Pathog. 2020;16(8):e1008742. https:\/\/doi.org\/10.1371\/journal.ppat.1008742","DOI":"10.1371\/journal.ppat.1008742"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.   Nightingale R, Chinoko B, Lesosky M, Rylance SJ, Mnesa B, Banda NPK, et al. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study. Thorax. 2022;77(11):1131-1139. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217190","DOI":"10.1136\/thoraxjnl-2021-217190"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.   Marx FM, Floyd S, Ayles H, Godfrey-Faussett P, Beyers N, Cohen T. High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions. Eur Respir J. 2016;48(4):1227-1230. https:\/\/doi.org\/10.1183\/13993003.00716-2016","DOI":"10.1183\/13993003.00716-2016"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.   Singh S, Allwood BW, Chiyaka TL, Kleyhans L, Naidoo CC, Moodley S, et al. Immunologic and imaging signatures in post tuberculosis lung disease. Tuberculosis (Edinb). 2022;136:102244. https:\/\/doi.org\/10.1016\/j.tube.2022.102244","DOI":"10.1016\/j.tube.2022.102244"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.   Gupta MB, Bagri S, Garg A, Singh DK, Choudhary P, Sahni S. Pulmonary function in cured pulmonary tuberculosis cases. Indian J Tuberc. 2022;69(4):535-538. https:\/\/doi.org\/10.1016\/j.ijtb.2021.08.024","DOI":"10.1016\/j.ijtb.2021.08.024"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.  Curry BD, van T Wout E, Maasdorp E, Nortje A, Irusen EM, Maree D, et al. Correlation between lung function tests and peak oxygen consumption in post-TB lung disease. Int J Tuberc Lung Dis. 2022;26(3):259-267. https:\/\/doi.org\/10.5588\/ijtld.21.0504","DOI":"10.5588\/ijtld.21.0504"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.   Sivaranjini S, Vanamail P, Eason J. Six minute walk test in people with tuberculosis sequelae. Cardiopulm Phys Ther J. 2010;21(3):5-10. https:\/\/doi.org\/10.1097\/01823246-201021030-00002","DOI":"10.1097\/01823246-201021030-00002"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.   Pereira MC, Athanazio RA, Dalcin PTR, Figueiredo MRF, Gomes M, Freitas CG, et al. Brazilian consensus on non-cystic fibrosis bronchiectasis. J Bras Pneumol. 2019;45(4):e20190122. https:\/\/doi.org\/10.1590\/1806-3713\/e20190122","DOI":"10.1590\/1806-3713\/e20190122"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.   American Thoracic Society; American College of Chest Physicians. ATS\/ACCP Statement on cardiopulmonary exercise testing [published correction appears in Am J Respir Crit Care Med. 2003 May 15;1451-2]. Am J Respir Crit Care Med. 2003;167(2):211-277. https:\/\/doi.org\/10.1164\/rccm.167.2.211","DOI":"10.1164\/rccm.167.2.211"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41.   Venkitakrishnan R, Ramachandran D, Augustine J, Cleetus M. Inhaled corticosteroids and risk of tuberculosis-How bad is the risk?. Indian J Tuberc. 2022;69(2):128-130. https:\/\/doi.org\/10.1016\/j.ijtb.2021.06.010","DOI":"10.1016\/j.ijtb.2021.06.010"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42.   Mart\u00ednez-Garc\u00eda M\u00c1, Oscullo G, Garc\u00eda-Ortega A, Matera MG, Rogliani P, Cazzola M. Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review. Drugs. 2022;82(14):1453-1468. https:\/\/doi.org\/10.1007\/s40265-022-01785-1","DOI":"10.1007\/s40265-022-01785-1"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.  Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018;13(4):e0193732. https:\/\/doi.org\/10.1371\/journal.pone.0193732","DOI":"10.1371\/journal.pone.0193732"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44.   Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968. https:\/\/doi.org\/10.1183\/09031936.05.00035205","DOI":"10.1183\/09031936.05.00035205"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.  Crapo RO, Jensen RL, Hegewald M, Tashkin DP. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1525-1531. https:\/\/doi.org\/10.1164\/ajrccm.160.5.9806006","DOI":"10.1164\/ajrccm.160.5.9806006"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.  Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-1446. https:\/\/doi.org\/10.1183\/09031936.00150314","DOI":"10.1183\/09031936.00150314"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47.  Jones SE, Kon SS, Canavan JL, Patel MS, Clark AL, Nolan CM, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax. 2013;68(11):1015-1020. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203576","DOI":"10.1136\/thoraxjnl-2013-203576"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.  Gr\u00f8nseth R, Vollmer WM, Hardie JA, \u00d3lafsd\u00f3ttir IS, Lamprecht B, Buist AS, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610-1620. https:\/\/doi.org\/10.1183\/09031936.00036813","DOI":"10.1183\/09031936.00036813"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49.  Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. https:\/\/doi.org\/10.1136\/thx.54.7.581","DOI":"10.1136\/thx.54.7.581"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"50.  Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381. https:\/\/doi.org\/10.1249\/00005768-198205000-00012","DOI":"10.1249\/00005768-198205000-00012"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51.  Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs. 1989;14(6):323-325. https:\/\/doi.org\/10.1002\/j.2048-7940.1989.tb01129.x","DOI":"10.1002\/j.2048-7940.1989.tb01129.x"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52.  Sancho J, Servera E, D\u00edaz J, Mar\u00edn J. Comparison of peak cough flows measured by pneumotachograph and a portable peak flow meter. Am J Phys Med Rehabil. 2004;83(8):608-612. https:\/\/doi.org\/10.1097\/01.PHM.0000133431.70907.A2","DOI":"10.1097\/01.phm.0000133431.70907.a2"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53.   American Thoracic Society\/European Respiratory Society. ATS\/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624. https:\/\/doi.org\/10.1164\/rccm.166.4.518","DOI":"10.1164\/rccm.166.4.518"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54.  Kim SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737-742. https:\/\/doi.org\/10.3346\/jkms.2015.30.6.737","DOI":"10.3346\/jkms.2015.30.6.737"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55.  Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]. Bethesda: GOLD [cited 2023 May 29]. 2020 Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report. Available from: https:\/\/goldcopd.org\/2023-gold-report-2\/","DOI":"10.12659\/msm.942672"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56.  Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622-626. https:\/\/doi.org\/10.1111\/j.1532-5415.1968.tb02103.x","DOI":"10.1111\/j.1532-5415.1968.tb02103.x"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57.   Datta S, Gilman RH, Montoya R, Quevedo Cruz L, Valencia T, Huff D, et al. Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study. Eur Respir J. 2020;56(2):1900495. https:\/\/doi.org\/10.1183\/13993003.00495-2019","DOI":"10.1183\/13993003.00495-2019"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58.  Silva PA, Soares SM, Santos JF, Silva LB. Cut-off point for WHOQOL-bref as a measure of quality of life of older adults. Rev Saude Publica. 2014;48(3):390-397. https:\/\/doi.org\/10.1590\/S0034-8910.2014048004912","DOI":"10.1590\/s0034-8910.2014048004912"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59. Jo YS, Park S, Kim DK, Yoo CG, Lee CH. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients. BMC Pulm Med. 2018;18(1):38. https:\/\/doi.org\/10.1186\/s12890-018-0601-0","DOI":"10.1186\/s12890-018-0601-0"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60. Nasiri MJ, Silva DR, Rommasi F, Zahmatkesh MM, Tajabadi Z, Khelghati F, et al. Vaccination in post-tuberculosis lung disease management: A review of the evidence [published online ahead of print, 2023 Sep 5]. Pulmonology. 2023;S2531-0437(23)00129-0. https:\/\/doi.org\/10.1016\/j.pulmoe.2023.07.002","DOI":"10.1016\/j.pulmoe.2023.07.002"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"61.  Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary Rehabilitation in COVID-19 pa-tients: A scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020;66(4):480-494. https:\/\/doi.org\/10.5606\/tftrd.2020.6889","DOI":"10.5606\/tftrd.2020.6889"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:51:52Z","timestamp":1701186712000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/3906\/en-US\/brazilian-thoracic-association-recommendations-for-the-management-of-post-tuberculosis-lung-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":61,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20230269","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]}}}